Qscan deploys CARPL.ai to bring real-world AI to radiologists across Australia

Brisbane, Australia, October 23rd, 2025

In a move that signals how radiology AI is entering mainstream clinical use, Qscan Group, one of Australia’s largest outpatient imaging networks, has deployed CARPL.ai, the world’s largest AI marketplace for radiology, directly within its Intelerad PACS environment to power its next generation of AI-assisted reporting workflows.

The deployment enables Qscan’s radiologists to access and validate AI algorithms including tools supporting Australia’s National Lung Cancer Screening Program from within their existing PACS interface, without disrupting workflows.
 This marks one of the first large-scale, fully embedded AI marketplace integrations in the Australian imaging landscape.

"Qscan is extremely impressed by CARPL’s AI platform. Their unique approach that allows us to validate AI algorithms before using them through a single customized viewer that is deeply integrated with PACS is very valuable, We are currently using CARPL for the Lung Cancer Screening program and are seeing exponentially better radiologist productivity and outcomes", said Gary Shepherd, Chief Executive Officer, Qscan.

The partnership builds on Qscan’s decade-long collaboration with Intelerad, which provides enterprise imaging software to health systems globally. The CARPL Intelerad partnership ensures AI results appear natively within the radiologist’s viewer turning AI insights into actionable reporting support.

“This three-way collaboration ensures Qscan’s radiologists can access best-in-class AI tools directly within the Intelerad environment,” said Cemil Browne, VP & GM, Oceania, Intelerad. “The result is faster, more accurate diagnoses and smoother patient throughput.”

For CARPL.ai, this represents another milestone in scaling workflow-integrated AI adoption.

“The National Lung Cancer Screening Program has been a great opportunity to help Australian radiologists with cutting-edge AI models,” said Vidur Mahajan, CEO, CARPL.ai. “Our teams co-designed the solution with Qscan’s RadX group and delivered it fully compliant with NLCSLP guidelines in just three months.”

CARPL.ai’s platform offers more than 200 AI models across multiple clinical use cases, enabling hospitals and imaging groups to test, benchmark, and deploy tools through a single interface integrated with existing PACS/RIS systems.

The Qscan implementation underscores a broader shift in radiology: AI adoption moving from pilot experiments to real-world deployment at scale, driven by platform interoperability and workflow-native design.

About Qscan
QScan is a leading Australian provider of diagnostic and interventional radiology, operating a national network of over 80 clinics. Performing over 1.5 million scans annually, its 150+ subspecialty-trained radiologists utilize state-of-the-art technology, including 3T MRI and PET-CT. The group is committed to leveraging advanced AI platforms and delivering compassionate, high-quality patient care and clinical excellence.

About Intelerad
Intelerad is a leading global provider of medical imaging software, trusted by nearly 2,500 healthcare organizations to manage billions of images. Its comprehensive enterprise portfolio, featuring IntelePACS, InteleOrchestrator, and a cloud-native VNA, streamline diagnostic viewing and automates complex workflows. By unifying disparate systems and integrating CARPL.ai, Intelerad empowers clinicians to accelerate diagnoses and improve patient outcomes.

About CARPL.ai
CARPL.ai is the world's largest Radiology AI marketplace, offering 200+ applications from 80+ partners with global regulatory clearances. The platform enables radiologists to seamlessly access, assess, and integrate AI solutions via a single interface for testing, deployment, and monitoring. CARPL integrates with leading PACS systems, serving as the complete orchestration layer for responsible and scalable AI adoption in radiology.

For any PR or Media related queries please reach out to shruti.singhal@carpl.ai